Replies to post #230370 on Biotech Values

[DewDiligence]

RARX addendum—Arbs could’ve made 18.5% in two weeks if they had bought on Mar 18 (#msg-154416552). The price cratered that day, not because of anything specific to RARX, but rather from general dysfunction in the securities markets.